Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2021	Nov. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,086,476)	$ (5,395,192)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount	0	1,885,587
Loss on debt extinguishment	0	1,092,295
Depreciation expense	0	4,413
Impairment Loss	400,000	0
Inventory write-off	206,342	195,264
Gain on Note Payable Forgiveness	(135,165)
Derivative (gain)/loss		(4,312,338)
Issuance of common shares for services	35,000
Provision for bad debts	5,024	99,207
Changes in operating assets and liabilities:
Accounts receivable	46,402	117,356
Prepaid expenses	(2,966)	13,148
Inventory	131,301	667,995
Accounts payable and accrued liabilities	2,020,186	3,635,265
Cash used in operating activities	(380,354)	(1,997,000)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from PPP loan	0	135,165
Proceeds from convertible debt	0	936,168
Proceeds from NCI Investment in Brain Armor	300,000	0
Cash provided by financing activities	300,000	1,071,333
NET CHANGE IN CASH AND CASH EQUIVALENTS	(80,354)	(925,667)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	88,007	1,013,674
CASH AND CASH EQUIVALENTS AT END OF YEAR	7,653	88,007
Supplemental disclosure of cash flow information:
Income taxes	0	0
Interest	$ 0	$ 0